Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 18/20 | 0.94 |
| ▸ | CNR1 | P21554 | 16/20 | 0.94 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17623206 | 0.91 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL30641096 | 0.90 | CNR2 (0.80) | CNR2CNR1 | |
| SCHEMBL17613432 | 0.90 | CNR2 (0.79) | CNR2CNR1 | |
| SCHEMBL29871057 | 0.90 | CNR2 (0.80) | CNR2CNR1 | |
| SCHEMBL17613441 | 0.88 | CNR2 (0.79) | CNR2CNR1 | |
| SCHEMBL17613433 | 0.86 | CNR2 (0.94) | CNR2CNR1 | |
| SCHEMBL30353011 | 0.86 | CNR2 (0.94) | CNR2CNR1 | |
| SCHEMBL17613442 | 0.85 | CNR2 (0.75) | CNR2CNR1 | |
| SCHEMBL31052985 | 0.82 | CNR2 (0.81) | CNR2CNR1 | |
| SCHEMBL30641112 | 0.81 | CNR2 (0.94) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4618980-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | Freedom Biosciences, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3664795-B1 | CANNABIS AND DERIVATIVES THEREOF FOR THE TREATMENT OF PAIN AND INFLAMMATION RELATED WITH DENTAL PULP AND BONE REGENERATION RELATED TO DENTAL JAW BONE DEFECTS | CANNIBITE BVBA (BE) | 2024-06-19 | — | — | EP | claimed |
| WO-2024107445-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES, INC. (US) | 2024-05-23 | — | — | WO | claimed |
| CN-117877567-A | Metabolic marker for clinical early diagnosis of smoke disease and application thereof | 河南省人民医院 | 2024-04-12 | — | — | CN | claimed |
| CN-117805259-A | Method for rapidly analyzing 87 synthetic cannabinoids and metabolites thereof in urine after enzymolysis | 司法鉴定科学研究院 | 2024-04-02 | — | — | CN | claimed |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | FREEDOM BIOSCIENCES INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4646477-A2 | METHODS AND COMPOSITIONS FOR DISPLAYING PEPTIDE LIBRARIES | Board of Regents, The University of Texas System (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-4618980-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | Freedom Biosciences, Inc. (US) | 2025-09-24 | — | — | EP | disclosed |
| US-20250241933-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) | 2025-07-31 | — | — | US | disclosed |
| CN-120009249-A | Synthetic cannabinoid classification method | 中国科学院新疆理化技术研究所 | 2025-05-16 | — | — | CN | disclosed |
| EP-4543431-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119403548-A | Method of treating sleep apnea with a combination of cannabinoid and carbonic anhydrase inhibitors | 爱普宁公司(特拉华) | 2025-02-07 | — | — | CN | disclosed |
| CN-116297923-A | Rapid identification method for indole and indazole type synthetic cannabinoid novel psychoactive substance structure | 广西大学 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023102541-A1 | METHODS AND COMPOSITIONS RELATED TO ENGINEERED CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-06-08 | — | — | WO | disclosed |
| US-11612581-B2 | Cannabis and derivatives thereof for the treatment of pain and inflammation related with dental pulp and bone regeneration related to dental jaw bone defects | CANNIBITE BVBA | 2023-03-28 | — | — | US | disclosed |
| WO-2022221613-A1 | COMBINATION OF A NOREPINEPHRINE REUPTAKE INHIBITOR AND A CANNABINOID FOR USE IN TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) (US) | 2022-10-20 | — | — | WO | disclosed |
| CN-114942239-A | Composition, kit and method for rapidly detecting synthetic cannabinoid in tobacco tar | 合肥市公安局刑事警察支队 | 2022-08-26 | — | — | CN | disclosed |
| US-20160084859-A1 | DETECTION OF INDAZOLE SYNTHETIC CANNABINOIDS | RANDOX LABORATORIES LIMITED (GB) | 2016-03-24 | — | — | US | disclosed |
| EP-2998743-A2 | DETECTION OF INDAZOLE SYNTHETIC CANNABINOIDS | Randox Laboratories Ltd. (GB) | 2016-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160084859-A1 | DETECTION OF INDAZOLE SYNTHETIC CANNABINOIDS | CNR2, CNR1, HRH4 | CNR2 1/4885CNR1 2/4885 |
| US-20250360137-A1 | ENHANCEMENT OF THE EFFICACY OF SEROTONERGIC PSYCHEDELIC DRUGS IN THE TREATMENT OR PREVENTION OF CERTAIN NEUROPSYCHIATRIC DISORDERS THROUGH INHIBITION OF TYPE-9 PHOSPHODIESTERASES | PDE9A, PDE3A, PDE2A | CNR2 204/4885CNR1 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.